Sam K. Srivastava, Council Chair, is the chief executive officer of WCG Clinical, a global leader of clintech solutions that improve the quality and efficiency of clinical research and enables biopharma, CROs and institutions to accelerate the delivery of new treatments and therapies to patients. He is a transformative leader with a proven track record of driving growth and innovation in healthcare.
Prior to WCG, Sam served as chief executive officer of NeueHealth, a tech-enabled, risk bearing care delivery company with over 1M consumers across 17 states through owned clinics, partnered affiliates and high performing value-based networks. Sam was also chief executive officer of Magellan Healthcare, a leading behavioral, specialty and pharmacy management company serving 50M consumers worldwide. During his tenure, the company doubled in size by launching the nation’s first health plan for the seriously mentally ill, developing digital therapeutics and advanced illness programs. Prior to that, he worked at Cigna Healthcare as president of the national employer and Medicare businesses. He also led US strategy and development, that included the acquisition of HealthSpring and the launch of Cigna Ventures.
Sam has held executive positions at UnitedHealth Group and HealthNet (Centene). He also served as a management consultant in the US and Europe, developing integrated delivery systems for providers, insurers and governments.
Sam serves as the Yale School of Public Health advisory council chair and Recovery Centers of America board director. He is a frequent national speaker and has testified to Congress regarding the opioid crisis aiding in the passage of the bipartisan Support Act. Sam graduated from Kent State University with Bachelor of Arts in medical science and humanities and completed graduate work at Yale University in health care management.
He is married to Dr. Lisbet S. Lundsberg, an epidemiologist at the Yale School of Medicine. They have four daughters and reside in Wilton, Connecticut.